Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Cancer|December 31, 2013
Pain palliation measurement in cancer clinical trials: the US Food and Drug Administration perspectiveEthan Basch, Ann Marie Trentacosti, Laurie B Burke, et al.
Cancer|June 15, 2013
Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancerKaren A Autio, Neeta Pandit-Taskar, Jorge A Carrasquillo, et al.
Journal of Immunotherapy and Precision Oncology|December 25, 2023
Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate CancerDaniel Vargas P de Almeida, Justine M Anderson, Daniel C Danila, et al.
Journal for Immunotherapy of Cancer|July 24, 2021
CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding studyRachel E Sanborn, Omid Hamid, Elisabeth Ge de Vries, et al.
Biological Psychiatry|April 18, 2002
Early physical and sexual abuse associated with an adverse course of bipolar illnessGabriele S Leverich, Susan L McElroy, Trisha Suppes, et al.
Journal of Oncology Practice|August 15, 2013
Prevalence of pain and analgesic use in men with metastatic prostate cancer using a patient-reported outcome measureKaren A Autio, Antonia V Bennett, Xiaoyu Jia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2024
Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate CancerMatthew C Dallos, Aleksandar Z Obradovic, Patrick McCann, et al.
The Prostate|May 10, 2022
Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data qualityNiamh M Keegan, Samantha E Vasselman, Ethan S Barnett, et al.
JAMA Oncology|July 7, 2018
Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical TrialKaren A Autio, Robert Dreicer, Justine Anderson, et al.
European Urology Oncology|August 2, 2024
Clinical, Imaging, and Technical Factors Associated with Successful Genomic Profiling of Bone Biopsy Tissue in Prostate CancerFourat Ridouani, H Alberto Vargas, Daniel J Holzwanger, et al.
Pageof 5